Patent · US Expired

5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1H-indoles: new 5-HT.sub.1F agonists

US5708008A · kind A · utility

45Cited by

18References

28Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

James E. Audia · Indianapolis, US
Bruce A. Dressman · Indianapolis, US
James J. Droste · Indianapolis, US
James E. Fritz · Greenwood, US
Stephen W. Kaldor · Indianapolis, US
Daniel James Koch · Indianapolis, US
Joseph H. Krushinski, Jr. · Indianapolis, US
Jeffrey S. Nissen · Indianapolis, US
Vincent Patrick Rocco · Indianapolis, US
John M. Schaus · Zionsville, US
Dennis C. Thompson · Indianapolis, US

Key dates

Filing date	Mar 20, 1996
Grant date	Jan 13, 1998
Priority date	—
Expiry date	Mar 20, 2016

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/582
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This invention provides novel 5-HT.sub.1F agonists of Formula I ##STR1## where A--B, R, R.sup.1 and X are as defined in the specification, which are useful for the treatment of migraine and associated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.